Skip to main content

Table 1 Basic information for the studies included in the meta-analysis

From: Genetic relationship between IL-10 gene polymorphisms and the risk of clinical atopic dermatitis

First author, Year

[Ref.]

Ethnicity

Country

SNPs

Control

Case

Genotyping method

HWE P

XX/XY/YY

Source

XX/XY/YY

Arkwright, 2001

[32]

Mixed

UK

-1082A/G

16/21/13

PB

22/30/16

ARMS-PCR

0.27

Babic, 2016

[31]

Caucasian

Croatia

-1082A/G

25/107*

PB

9/28*

KASP + competitive ASPCR

>0.05

Behniafard, 2018

[37]

Asian

Iran

-1082A/G

53/75/12

PB

30/46/13

PCR-SSP

0.04

-819 T/C

12/57/71

PB

6/42/41

PCR-SSP

0.91

-592A/C

12/57/71

PB

5/42/42

PCR-SSP

0.91

Bin, 2018

[20]

Asian

Saudi Arabia

-1082A/G

36/159/16

PB

30/53/21

ARMS-PCR

< 0.05

-819 T/C

21/102/88

PB

14/54/36

ARMS-PCR

0.27

-592A/C

21/102/88

PB

14/54/36

ARMS-PCR

0.27

Chang, 2006

[21]

Asian

China

-1082A/G

344#/28#

PB

174#/14#

gene sequecing

>0.05

-819 T/C

250#/122#

PB

132#/56#

gene sequecing

>0.05

-592A/C

250#/122#

PB

132#/56#

gene sequecing

>0.05

Esposito, 2015

[16]

Caucasian

Italy

-1082A/G

38/60/20

PB

50/41/10

TaqMan Array

0.65

-592A/C

6/39/73

PB

13/49/42

TaqMan Array

0.79

Jain, 2017

[15]

Asian

India

-1082A/G

7/31/0

PB

23/15/0

ARMS-PCR

< 0.05

-819 T/C

1/28/9

PB

8/26/4

ARMS-PCR

< 0.05

-592A/C

1/28/9

PB

8/26/4

ARMS-PCR

< 0.05

Kayserova, 2012

[17]

Caucasian

Czech Republic

-1082A/G

20/71/11

PB

29/43/16

PCR-SSP

< 0.05

-819 T/C

4/50/48

PB

7/26/55

PCR-SSP

0.04

-592A/C

5/48/49

PB

8/25/55

PCR-SSP

0.11

Lesiak, 2011

[19]

Caucasian

Poland

-1082A/G

67/89/48

PB

54/75/34

PCR-RFLP

0.09

Lesiak, 2014

[33]

Caucasian

Poland

-1082A/G

20/26/14

PB

25/35/16

PCR-RFLP

0.33

Reich, 2003

[34]

Caucasian

Germany

-1082A/G

49/118/47

PB

18/53/23

PCR-RFLP/sequencing

0.13

Sheng, 2018

[38]

Asian

China

-819 T/C

128/130/41

PB

83/154/63

Sequenom MassARRAY

0.39

Sohn, 2007

[18]

Asian

Korea

-1082A/G

124/15/1

PB

241/35/0

PCR-RFLP/sequencing

0.47

-819 T/C

66/68/6

PB

145/104/27

PCR-RFLP/sequencing

0.02

-592A/C

64/65/11

PB

137/110/29

PCR-RFLP/sequencing

0.32

Stavric, 2012

[35]

Caucasian

Macedonia

-1082A/G

70/212/17

PB

8/55/3

PCR-SSP

< 0.05

-819 T/C

155/125/19

PB

39/27/0

PCR-SSP

0.35

-592A/C

28/117/154

PB

3/27/36

PCR-SSP

0.40

Yinji, 2010

[30]

Asian

China

-1082A/G

109/20/0

PB

143/30/0

TaqMan

0.34

-819 T/C

55/60/14

PB

89/70/14

TaqMan

0.69

-592A/C

55/60/14

PB

89/70/14

TaqMan

0.69

Zakrzewski, 2010

[36]

Caucasian

Poland

-1082A/G

67/89/48

PB

54/75/34

PCR-RFLP

0.09

  1. Ref. reference, SNPs single nucleotide polymorphisms, XX AA genotype (−1082 A/G SNP), TT genotype (−819 T/C SNP), AA genotype (−592 A/C SNP), XY AG genotype (−1082 A/G SNP), TC genotype (−819 T/C SNP), AC genotype (−592 A/C SNP), YY GG genotype (− 1082 A/G SNP), CC genotype (− 819 T/C SNP), CC genotype (− 592 A/C SNP), PB population-based control, ARMS amplification refractory mutational system, PCR polymerase chain reaction; KASP Kompetitive Allele Specific PCR, ASPCR allele-specific PCR, SSP sequence specific primer, RFLP restriction fragment-length polymorphism, HWE Hardy-Weinberg equilibrium
  2. * the frequency data of AG + GG; # the frequency data of X, Y allele